The latest price target for Agilon Health (NYSE:AGL) was reported by Benchmark on April 2, 2026. The analyst firm set a price target for $13.00 expecting AGL to fall to within 12 months (a possible -46.79% downside). 21 analyst firms have reported ratings in the last year.

The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Benchmark, and Agilon Health maintained their buy rating.

The last upgrade for Agilon Health Inc happened on April 25, 2025 when Citigroup raised their price target to $5. Citigroup previously had a neutral for Agilon Health Inc.

The last downgrade for Agilon Health Inc happened on August 20, 2025 when Bernstein changed their price target from $4 to $1.4 for Agilon Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on April 2, 2026 so you should expect the next rating to be made available sometime around April 2, 2027.

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $1.50 to $13.00. The current price Agilon Health (AGL) is trading at is $24.43, which is out of the analyst’s predicted range.